MOL ONCOL 润色咨询

Molecular Oncology

出版年份：2007 年文章数：1571 投稿命中率： 开通期刊会员，数据随心看

出版周期：Quarterly 自引率：1.7% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=805187, encodeId=5e8080518e5f, content=intial check之后 Awit EIC assignment，然后就是Under Review，这是送审稿人了么？还是编辑在自己审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/f8c6cedf590b428e995d7418b12fecdf/3ca40bdbedf6430d90d6ada162ebe274.jpg, createdBy=46eb5398335, createdName=投投投中中中, createdTime=Thu Jul 30 12:44:26 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096549, encodeId=de89209654996, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：刚收了一篇，一篇中规中矩的稿子，非主力课题的数据，投Cancer Letters拒稿后转投Molecular Oncology，修回要求补实验，补了大概2组图的数据量，二修后又提了点小问题就接受了。这个杂志对实验图片的审查是我见过最严格的，最后一轮修回，要求提交原始数据，最后我们提交了1G的原始数据，包括所有的重复。编辑校对及其细致，校对了两轮，花了一周时间。想混的还有实验重复次数不够的，还是建议不要投这个杂志了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d78400513, createdName=ms5000001747723382, createdTime=Thu Oct 27 21:39:31 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969727, encodeId=e73c969e273b, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3600.0<br>偏重的研究方向：肿瘤血管发育<br>经验分享：刚接收1篇，前期投Cancer Research不中投过来的<br>1.21投稿，3.2Major，3个reviewer，1一个小修接收，一个正常评审，一个问题较多<br>补实验2月，5.15修回，5.28接收<br>WB会要求原始曝光图及实验相关信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac4999328, createdName=fangchao1989, createdTime=Sun May 30 23:47:54 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582589, encodeId=12c458258929, content=这个杂志接收后需要提供原始曝光图吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23d05177737, createdName=向快乐出发, createdTime=Fri Jan 03 00:00:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205617, encodeId=40dc120561e35, content=各位大佬，请教下这个杂志接受临床结合生信类的文章吗，万分感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Thu Mar 24 16:56:46 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002991, encodeId=ccdb10029912d, content=请问需要wb未剪裁的原始曝光图片么？我的wb都剪过了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Tue Jul 27 13:30:51 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082042, encodeId=761a1082042a6, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：杂志比较难得投，所有的都需要原图，wb可能要全膜，谨慎选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95db5541159, createdName=阳关月, createdTime=Mon Dec 20 11:17:44 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212420, encodeId=c805121242048, content=这杂志灌水的就别考虑了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220419/0ecfdd1b0b5d452097a52e6dc6c6e9fe/95751d975cfd4fa18ac95d4cb42e701e.png, createdBy=9d361953288, createdName=222222ddwdd, createdTime=Tue Apr 19 09:13:51 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196267, encodeId=e173119626ede, content=这个杂志有些文章质量真的可以，5-10分这一档算很不错的杂志了，很少国人灌水的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1dc5574811, createdName=ms3000001264860737, createdTime=Tue Feb 22 23:12:02 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585839, encodeId=f9e1585839db, content=这个杂志是欧洲生化协会的期刊，要求高，文章水平也高，不接受review，只进行review的邀稿，所以杂志if很结实，不是用大量review强行拉上去的。如果文章水平可以，可以投一投，一般的就不要浪费时间了。而且对质量要求高，造假的甭投了，被检查出来那就有意思了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/2d0413f4fd3b4a5f1acc9ccc7d585f61.jpg, createdBy=b9cb2546102, createdName=这是一个昵称, createdTime=Wed Mar 04 00:00:00 CST 2020, time=2020-03-04, status=1, ipAttribution=)]
    2020-07-30 投投投中中中

    intial check之后 Awit EIC assignment，然后就是Under Review，这是送审稿人了么？还是编辑在自己审？

    10

    展开10条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=805187, encodeId=5e8080518e5f, content=intial check之后 Awit EIC assignment，然后就是Under Review，这是送审稿人了么？还是编辑在自己审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/f8c6cedf590b428e995d7418b12fecdf/3ca40bdbedf6430d90d6ada162ebe274.jpg, createdBy=46eb5398335, createdName=投投投中中中, createdTime=Thu Jul 30 12:44:26 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096549, encodeId=de89209654996, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：刚收了一篇，一篇中规中矩的稿子，非主力课题的数据，投Cancer Letters拒稿后转投Molecular Oncology，修回要求补实验，补了大概2组图的数据量，二修后又提了点小问题就接受了。这个杂志对实验图片的审查是我见过最严格的，最后一轮修回，要求提交原始数据，最后我们提交了1G的原始数据，包括所有的重复。编辑校对及其细致，校对了两轮，花了一周时间。想混的还有实验重复次数不够的，还是建议不要投这个杂志了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d78400513, createdName=ms5000001747723382, createdTime=Thu Oct 27 21:39:31 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969727, encodeId=e73c969e273b, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3600.0<br>偏重的研究方向：肿瘤血管发育<br>经验分享：刚接收1篇，前期投Cancer Research不中投过来的<br>1.21投稿，3.2Major，3个reviewer，1一个小修接收，一个正常评审，一个问题较多<br>补实验2月，5.15修回，5.28接收<br>WB会要求原始曝光图及实验相关信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac4999328, createdName=fangchao1989, createdTime=Sun May 30 23:47:54 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582589, encodeId=12c458258929, content=这个杂志接收后需要提供原始曝光图吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23d05177737, createdName=向快乐出发, createdTime=Fri Jan 03 00:00:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205617, encodeId=40dc120561e35, content=各位大佬，请教下这个杂志接受临床结合生信类的文章吗，万分感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Thu Mar 24 16:56:46 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002991, encodeId=ccdb10029912d, content=请问需要wb未剪裁的原始曝光图片么？我的wb都剪过了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Tue Jul 27 13:30:51 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082042, encodeId=761a1082042a6, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：杂志比较难得投，所有的都需要原图，wb可能要全膜，谨慎选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95db5541159, createdName=阳关月, createdTime=Mon Dec 20 11:17:44 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212420, encodeId=c805121242048, content=这杂志灌水的就别考虑了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220419/0ecfdd1b0b5d452097a52e6dc6c6e9fe/95751d975cfd4fa18ac95d4cb42e701e.png, createdBy=9d361953288, createdName=222222ddwdd, createdTime=Tue Apr 19 09:13:51 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196267, encodeId=e173119626ede, content=这个杂志有些文章质量真的可以，5-10分这一档算很不错的杂志了，很少国人灌水的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1dc5574811, createdName=ms3000001264860737, createdTime=Tue Feb 22 23:12:02 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585839, encodeId=f9e1585839db, content=这个杂志是欧洲生化协会的期刊，要求高，文章水平也高，不接受review，只进行review的邀稿，所以杂志if很结实，不是用大量review强行拉上去的。如果文章水平可以，可以投一投，一般的就不要浪费时间了。而且对质量要求高，造假的甭投了，被检查出来那就有意思了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/2d0413f4fd3b4a5f1acc9ccc7d585f61.jpg, createdBy=b9cb2546102, createdName=这是一个昵称, createdTime=Wed Mar 04 00:00:00 CST 2020, time=2020-03-04, status=1, ipAttribution=)]
    2022-10-27 ms5000001747723382

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向：肿瘤
    经验分享：刚收了一篇，一篇中规中矩的稿子，非主力课题的数据，投Cancer Letters拒稿后转投Molecular Oncology，修回要求补实验，补了大概2组图的数据量，二修后又提了点小问题就接受了。这个杂志对实验图片的审查是我见过最严格的，最后一轮修回，要求提交原始数据，最后我们提交了1G的原始数据，包括所有的重复。编辑校对及其细致，校对了两轮，花了一周时间。想混的还有实验重复次数不够的，还是建议不要投这个杂志了。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=805187, encodeId=5e8080518e5f, content=intial check之后 Awit EIC assignment，然后就是Under Review，这是送审稿人了么？还是编辑在自己审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/f8c6cedf590b428e995d7418b12fecdf/3ca40bdbedf6430d90d6ada162ebe274.jpg, createdBy=46eb5398335, createdName=投投投中中中, createdTime=Thu Jul 30 12:44:26 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096549, encodeId=de89209654996, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：刚收了一篇，一篇中规中矩的稿子，非主力课题的数据，投Cancer Letters拒稿后转投Molecular Oncology，修回要求补实验，补了大概2组图的数据量，二修后又提了点小问题就接受了。这个杂志对实验图片的审查是我见过最严格的，最后一轮修回，要求提交原始数据，最后我们提交了1G的原始数据，包括所有的重复。编辑校对及其细致，校对了两轮，花了一周时间。想混的还有实验重复次数不够的，还是建议不要投这个杂志了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d78400513, createdName=ms5000001747723382, createdTime=Thu Oct 27 21:39:31 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969727, encodeId=e73c969e273b, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3600.0<br>偏重的研究方向：肿瘤血管发育<br>经验分享：刚接收1篇，前期投Cancer Research不中投过来的<br>1.21投稿，3.2Major，3个reviewer，1一个小修接收，一个正常评审，一个问题较多<br>补实验2月，5.15修回，5.28接收<br>WB会要求原始曝光图及实验相关信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac4999328, createdName=fangchao1989, createdTime=Sun May 30 23:47:54 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582589, encodeId=12c458258929, content=这个杂志接收后需要提供原始曝光图吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23d05177737, createdName=向快乐出发, createdTime=Fri Jan 03 00:00:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205617, encodeId=40dc120561e35, content=各位大佬，请教下这个杂志接受临床结合生信类的文章吗，万分感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Thu Mar 24 16:56:46 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002991, encodeId=ccdb10029912d, content=请问需要wb未剪裁的原始曝光图片么？我的wb都剪过了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Tue Jul 27 13:30:51 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082042, encodeId=761a1082042a6, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：杂志比较难得投，所有的都需要原图，wb可能要全膜，谨慎选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95db5541159, createdName=阳关月, createdTime=Mon Dec 20 11:17:44 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212420, encodeId=c805121242048, content=这杂志灌水的就别考虑了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220419/0ecfdd1b0b5d452097a52e6dc6c6e9fe/95751d975cfd4fa18ac95d4cb42e701e.png, createdBy=9d361953288, createdName=222222ddwdd, createdTime=Tue Apr 19 09:13:51 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196267, encodeId=e173119626ede, content=这个杂志有些文章质量真的可以，5-10分这一档算很不错的杂志了，很少国人灌水的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1dc5574811, createdName=ms3000001264860737, createdTime=Tue Feb 22 23:12:02 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585839, encodeId=f9e1585839db, content=这个杂志是欧洲生化协会的期刊，要求高，文章水平也高，不接受review，只进行review的邀稿，所以杂志if很结实，不是用大量review强行拉上去的。如果文章水平可以，可以投一投，一般的就不要浪费时间了。而且对质量要求高，造假的甭投了，被检查出来那就有意思了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/2d0413f4fd3b4a5f1acc9ccc7d585f61.jpg, createdBy=b9cb2546102, createdName=这是一个昵称, createdTime=Wed Mar 04 00:00:00 CST 2020, time=2020-03-04, status=1, ipAttribution=)]
    2021-05-30 fangchao1989

    审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3600.0
    偏重的研究方向：肿瘤血管发育
    经验分享：刚接收1篇，前期投Cancer Research不中投过来的
    1.21投稿，3.2Major，3个reviewer，1一个小修接收，一个正常评审，一个问题较多
    补实验2月，5.15修回，5.28接收
    WB会要求原始曝光图及实验相关信息

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=805187, encodeId=5e8080518e5f, content=intial check之后 Awit EIC assignment，然后就是Under Review，这是送审稿人了么？还是编辑在自己审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/f8c6cedf590b428e995d7418b12fecdf/3ca40bdbedf6430d90d6ada162ebe274.jpg, createdBy=46eb5398335, createdName=投投投中中中, createdTime=Thu Jul 30 12:44:26 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096549, encodeId=de89209654996, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：刚收了一篇，一篇中规中矩的稿子，非主力课题的数据，投Cancer Letters拒稿后转投Molecular Oncology，修回要求补实验，补了大概2组图的数据量，二修后又提了点小问题就接受了。这个杂志对实验图片的审查是我见过最严格的，最后一轮修回，要求提交原始数据，最后我们提交了1G的原始数据，包括所有的重复。编辑校对及其细致，校对了两轮，花了一周时间。想混的还有实验重复次数不够的，还是建议不要投这个杂志了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d78400513, createdName=ms5000001747723382, createdTime=Thu Oct 27 21:39:31 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969727, encodeId=e73c969e273b, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3600.0<br>偏重的研究方向：肿瘤血管发育<br>经验分享：刚接收1篇，前期投Cancer Research不中投过来的<br>1.21投稿，3.2Major，3个reviewer，1一个小修接收，一个正常评审，一个问题较多<br>补实验2月，5.15修回，5.28接收<br>WB会要求原始曝光图及实验相关信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac4999328, createdName=fangchao1989, createdTime=Sun May 30 23:47:54 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582589, encodeId=12c458258929, content=这个杂志接收后需要提供原始曝光图吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23d05177737, createdName=向快乐出发, createdTime=Fri Jan 03 00:00:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205617, encodeId=40dc120561e35, content=各位大佬，请教下这个杂志接受临床结合生信类的文章吗，万分感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Thu Mar 24 16:56:46 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002991, encodeId=ccdb10029912d, content=请问需要wb未剪裁的原始曝光图片么？我的wb都剪过了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Tue Jul 27 13:30:51 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082042, encodeId=761a1082042a6, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：杂志比较难得投，所有的都需要原图，wb可能要全膜，谨慎选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95db5541159, createdName=阳关月, createdTime=Mon Dec 20 11:17:44 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212420, encodeId=c805121242048, content=这杂志灌水的就别考虑了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220419/0ecfdd1b0b5d452097a52e6dc6c6e9fe/95751d975cfd4fa18ac95d4cb42e701e.png, createdBy=9d361953288, createdName=222222ddwdd, createdTime=Tue Apr 19 09:13:51 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196267, encodeId=e173119626ede, content=这个杂志有些文章质量真的可以，5-10分这一档算很不错的杂志了，很少国人灌水的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1dc5574811, createdName=ms3000001264860737, createdTime=Tue Feb 22 23:12:02 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585839, encodeId=f9e1585839db, content=这个杂志是欧洲生化协会的期刊，要求高，文章水平也高，不接受review，只进行review的邀稿，所以杂志if很结实，不是用大量review强行拉上去的。如果文章水平可以，可以投一投，一般的就不要浪费时间了。而且对质量要求高，造假的甭投了，被检查出来那就有意思了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/2d0413f4fd3b4a5f1acc9ccc7d585f61.jpg, createdBy=b9cb2546102, createdName=这是一个昵称, createdTime=Wed Mar 04 00:00:00 CST 2020, time=2020-03-04, status=1, ipAttribution=)]
    2020-01-03 向快乐出发

    这个杂志接收后需要提供原始曝光图吗？

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=805187, encodeId=5e8080518e5f, content=intial check之后 Awit EIC assignment，然后就是Under Review，这是送审稿人了么？还是编辑在自己审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/f8c6cedf590b428e995d7418b12fecdf/3ca40bdbedf6430d90d6ada162ebe274.jpg, createdBy=46eb5398335, createdName=投投投中中中, createdTime=Thu Jul 30 12:44:26 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096549, encodeId=de89209654996, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：刚收了一篇，一篇中规中矩的稿子，非主力课题的数据，投Cancer Letters拒稿后转投Molecular Oncology，修回要求补实验，补了大概2组图的数据量，二修后又提了点小问题就接受了。这个杂志对实验图片的审查是我见过最严格的，最后一轮修回，要求提交原始数据，最后我们提交了1G的原始数据，包括所有的重复。编辑校对及其细致，校对了两轮，花了一周时间。想混的还有实验重复次数不够的，还是建议不要投这个杂志了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d78400513, createdName=ms5000001747723382, createdTime=Thu Oct 27 21:39:31 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969727, encodeId=e73c969e273b, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3600.0<br>偏重的研究方向：肿瘤血管发育<br>经验分享：刚接收1篇，前期投Cancer Research不中投过来的<br>1.21投稿，3.2Major，3个reviewer，1一个小修接收，一个正常评审，一个问题较多<br>补实验2月，5.15修回，5.28接收<br>WB会要求原始曝光图及实验相关信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac4999328, createdName=fangchao1989, createdTime=Sun May 30 23:47:54 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582589, encodeId=12c458258929, content=这个杂志接收后需要提供原始曝光图吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23d05177737, createdName=向快乐出发, createdTime=Fri Jan 03 00:00:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205617, encodeId=40dc120561e35, content=各位大佬，请教下这个杂志接受临床结合生信类的文章吗，万分感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Thu Mar 24 16:56:46 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002991, encodeId=ccdb10029912d, content=请问需要wb未剪裁的原始曝光图片么？我的wb都剪过了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Tue Jul 27 13:30:51 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082042, encodeId=761a1082042a6, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：杂志比较难得投，所有的都需要原图，wb可能要全膜，谨慎选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95db5541159, createdName=阳关月, createdTime=Mon Dec 20 11:17:44 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212420, encodeId=c805121242048, content=这杂志灌水的就别考虑了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220419/0ecfdd1b0b5d452097a52e6dc6c6e9fe/95751d975cfd4fa18ac95d4cb42e701e.png, createdBy=9d361953288, createdName=222222ddwdd, createdTime=Tue Apr 19 09:13:51 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196267, encodeId=e173119626ede, content=这个杂志有些文章质量真的可以，5-10分这一档算很不错的杂志了，很少国人灌水的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1dc5574811, createdName=ms3000001264860737, createdTime=Tue Feb 22 23:12:02 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585839, encodeId=f9e1585839db, content=这个杂志是欧洲生化协会的期刊，要求高，文章水平也高，不接受review，只进行review的邀稿，所以杂志if很结实，不是用大量review强行拉上去的。如果文章水平可以，可以投一投，一般的就不要浪费时间了。而且对质量要求高，造假的甭投了，被检查出来那就有意思了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/2d0413f4fd3b4a5f1acc9ccc7d585f61.jpg, createdBy=b9cb2546102, createdName=这是一个昵称, createdTime=Wed Mar 04 00:00:00 CST 2020, time=2020-03-04, status=1, ipAttribution=)]
    2022-03-24 wylj

    各位大佬，请教下这个杂志接受临床结合生信类的文章吗，万分感激

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=805187, encodeId=5e8080518e5f, content=intial check之后 Awit EIC assignment，然后就是Under Review，这是送审稿人了么？还是编辑在自己审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/f8c6cedf590b428e995d7418b12fecdf/3ca40bdbedf6430d90d6ada162ebe274.jpg, createdBy=46eb5398335, createdName=投投投中中中, createdTime=Thu Jul 30 12:44:26 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096549, encodeId=de89209654996, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：刚收了一篇，一篇中规中矩的稿子，非主力课题的数据，投Cancer Letters拒稿后转投Molecular Oncology，修回要求补实验，补了大概2组图的数据量，二修后又提了点小问题就接受了。这个杂志对实验图片的审查是我见过最严格的，最后一轮修回，要求提交原始数据，最后我们提交了1G的原始数据，包括所有的重复。编辑校对及其细致，校对了两轮，花了一周时间。想混的还有实验重复次数不够的，还是建议不要投这个杂志了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d78400513, createdName=ms5000001747723382, createdTime=Thu Oct 27 21:39:31 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969727, encodeId=e73c969e273b, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3600.0<br>偏重的研究方向：肿瘤血管发育<br>经验分享：刚接收1篇，前期投Cancer Research不中投过来的<br>1.21投稿，3.2Major，3个reviewer，1一个小修接收，一个正常评审，一个问题较多<br>补实验2月，5.15修回，5.28接收<br>WB会要求原始曝光图及实验相关信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac4999328, createdName=fangchao1989, createdTime=Sun May 30 23:47:54 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582589, encodeId=12c458258929, content=这个杂志接收后需要提供原始曝光图吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23d05177737, createdName=向快乐出发, createdTime=Fri Jan 03 00:00:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205617, encodeId=40dc120561e35, content=各位大佬，请教下这个杂志接受临床结合生信类的文章吗，万分感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Thu Mar 24 16:56:46 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002991, encodeId=ccdb10029912d, content=请问需要wb未剪裁的原始曝光图片么？我的wb都剪过了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Tue Jul 27 13:30:51 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082042, encodeId=761a1082042a6, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：杂志比较难得投，所有的都需要原图，wb可能要全膜，谨慎选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95db5541159, createdName=阳关月, createdTime=Mon Dec 20 11:17:44 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212420, encodeId=c805121242048, content=这杂志灌水的就别考虑了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220419/0ecfdd1b0b5d452097a52e6dc6c6e9fe/95751d975cfd4fa18ac95d4cb42e701e.png, createdBy=9d361953288, createdName=222222ddwdd, createdTime=Tue Apr 19 09:13:51 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196267, encodeId=e173119626ede, content=这个杂志有些文章质量真的可以，5-10分这一档算很不错的杂志了，很少国人灌水的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1dc5574811, createdName=ms3000001264860737, createdTime=Tue Feb 22 23:12:02 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585839, encodeId=f9e1585839db, content=这个杂志是欧洲生化协会的期刊，要求高，文章水平也高，不接受review，只进行review的邀稿，所以杂志if很结实，不是用大量review强行拉上去的。如果文章水平可以，可以投一投，一般的就不要浪费时间了。而且对质量要求高，造假的甭投了，被检查出来那就有意思了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/2d0413f4fd3b4a5f1acc9ccc7d585f61.jpg, createdBy=b9cb2546102, createdName=这是一个昵称, createdTime=Wed Mar 04 00:00:00 CST 2020, time=2020-03-04, status=1, ipAttribution=)]
    2021-07-27 145d4029m98暂无昵称

    请问需要wb未剪裁的原始曝光图片么？我的wb都剪过了。。。

    7

    展开7条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=805187, encodeId=5e8080518e5f, content=intial check之后 Awit EIC assignment，然后就是Under Review，这是送审稿人了么？还是编辑在自己审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/f8c6cedf590b428e995d7418b12fecdf/3ca40bdbedf6430d90d6ada162ebe274.jpg, createdBy=46eb5398335, createdName=投投投中中中, createdTime=Thu Jul 30 12:44:26 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096549, encodeId=de89209654996, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：刚收了一篇，一篇中规中矩的稿子，非主力课题的数据，投Cancer Letters拒稿后转投Molecular Oncology，修回要求补实验，补了大概2组图的数据量，二修后又提了点小问题就接受了。这个杂志对实验图片的审查是我见过最严格的，最后一轮修回，要求提交原始数据，最后我们提交了1G的原始数据，包括所有的重复。编辑校对及其细致，校对了两轮，花了一周时间。想混的还有实验重复次数不够的，还是建议不要投这个杂志了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d78400513, createdName=ms5000001747723382, createdTime=Thu Oct 27 21:39:31 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969727, encodeId=e73c969e273b, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3600.0<br>偏重的研究方向：肿瘤血管发育<br>经验分享：刚接收1篇，前期投Cancer Research不中投过来的<br>1.21投稿，3.2Major，3个reviewer，1一个小修接收，一个正常评审，一个问题较多<br>补实验2月，5.15修回，5.28接收<br>WB会要求原始曝光图及实验相关信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac4999328, createdName=fangchao1989, createdTime=Sun May 30 23:47:54 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582589, encodeId=12c458258929, content=这个杂志接收后需要提供原始曝光图吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23d05177737, createdName=向快乐出发, createdTime=Fri Jan 03 00:00:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205617, encodeId=40dc120561e35, content=各位大佬，请教下这个杂志接受临床结合生信类的文章吗，万分感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Thu Mar 24 16:56:46 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002991, encodeId=ccdb10029912d, content=请问需要wb未剪裁的原始曝光图片么？我的wb都剪过了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Tue Jul 27 13:30:51 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082042, encodeId=761a1082042a6, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：杂志比较难得投，所有的都需要原图，wb可能要全膜，谨慎选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95db5541159, createdName=阳关月, createdTime=Mon Dec 20 11:17:44 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212420, encodeId=c805121242048, content=这杂志灌水的就别考虑了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220419/0ecfdd1b0b5d452097a52e6dc6c6e9fe/95751d975cfd4fa18ac95d4cb42e701e.png, createdBy=9d361953288, createdName=222222ddwdd, createdTime=Tue Apr 19 09:13:51 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196267, encodeId=e173119626ede, content=这个杂志有些文章质量真的可以，5-10分这一档算很不错的杂志了，很少国人灌水的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1dc5574811, createdName=ms3000001264860737, createdTime=Tue Feb 22 23:12:02 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585839, encodeId=f9e1585839db, content=这个杂志是欧洲生化协会的期刊，要求高，文章水平也高，不接受review，只进行review的邀稿，所以杂志if很结实，不是用大量review强行拉上去的。如果文章水平可以，可以投一投，一般的就不要浪费时间了。而且对质量要求高，造假的甭投了，被检查出来那就有意思了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/2d0413f4fd3b4a5f1acc9ccc7d585f61.jpg, createdBy=b9cb2546102, createdName=这是一个昵称, createdTime=Wed Mar 04 00:00:00 CST 2020, time=2020-03-04, status=1, ipAttribution=)]
    2021-12-20 阳关月

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享：杂志比较难得投，所有的都需要原图，wb可能要全膜，谨慎选择

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=805187, encodeId=5e8080518e5f, content=intial check之后 Awit EIC assignment，然后就是Under Review，这是送审稿人了么？还是编辑在自己审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/f8c6cedf590b428e995d7418b12fecdf/3ca40bdbedf6430d90d6ada162ebe274.jpg, createdBy=46eb5398335, createdName=投投投中中中, createdTime=Thu Jul 30 12:44:26 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096549, encodeId=de89209654996, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：刚收了一篇，一篇中规中矩的稿子，非主力课题的数据，投Cancer Letters拒稿后转投Molecular Oncology，修回要求补实验，补了大概2组图的数据量，二修后又提了点小问题就接受了。这个杂志对实验图片的审查是我见过最严格的，最后一轮修回，要求提交原始数据，最后我们提交了1G的原始数据，包括所有的重复。编辑校对及其细致，校对了两轮，花了一周时间。想混的还有实验重复次数不够的，还是建议不要投这个杂志了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d78400513, createdName=ms5000001747723382, createdTime=Thu Oct 27 21:39:31 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969727, encodeId=e73c969e273b, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3600.0<br>偏重的研究方向：肿瘤血管发育<br>经验分享：刚接收1篇，前期投Cancer Research不中投过来的<br>1.21投稿，3.2Major，3个reviewer，1一个小修接收，一个正常评审，一个问题较多<br>补实验2月，5.15修回，5.28接收<br>WB会要求原始曝光图及实验相关信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac4999328, createdName=fangchao1989, createdTime=Sun May 30 23:47:54 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582589, encodeId=12c458258929, content=这个杂志接收后需要提供原始曝光图吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23d05177737, createdName=向快乐出发, createdTime=Fri Jan 03 00:00:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205617, encodeId=40dc120561e35, content=各位大佬，请教下这个杂志接受临床结合生信类的文章吗，万分感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Thu Mar 24 16:56:46 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002991, encodeId=ccdb10029912d, content=请问需要wb未剪裁的原始曝光图片么？我的wb都剪过了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Tue Jul 27 13:30:51 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082042, encodeId=761a1082042a6, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：杂志比较难得投，所有的都需要原图，wb可能要全膜，谨慎选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95db5541159, createdName=阳关月, createdTime=Mon Dec 20 11:17:44 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212420, encodeId=c805121242048, content=这杂志灌水的就别考虑了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220419/0ecfdd1b0b5d452097a52e6dc6c6e9fe/95751d975cfd4fa18ac95d4cb42e701e.png, createdBy=9d361953288, createdName=222222ddwdd, createdTime=Tue Apr 19 09:13:51 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196267, encodeId=e173119626ede, content=这个杂志有些文章质量真的可以，5-10分这一档算很不错的杂志了，很少国人灌水的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1dc5574811, createdName=ms3000001264860737, createdTime=Tue Feb 22 23:12:02 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585839, encodeId=f9e1585839db, content=这个杂志是欧洲生化协会的期刊，要求高，文章水平也高，不接受review，只进行review的邀稿，所以杂志if很结实，不是用大量review强行拉上去的。如果文章水平可以，可以投一投，一般的就不要浪费时间了。而且对质量要求高，造假的甭投了，被检查出来那就有意思了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/2d0413f4fd3b4a5f1acc9ccc7d585f61.jpg, createdBy=b9cb2546102, createdName=这是一个昵称, createdTime=Wed Mar 04 00:00:00 CST 2020, time=2020-03-04, status=1, ipAttribution=)]
    2022-04-19 222222ddwdd

    这杂志灌水的就别考虑了。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=805187, encodeId=5e8080518e5f, content=intial check之后 Awit EIC assignment，然后就是Under Review，这是送审稿人了么？还是编辑在自己审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/f8c6cedf590b428e995d7418b12fecdf/3ca40bdbedf6430d90d6ada162ebe274.jpg, createdBy=46eb5398335, createdName=投投投中中中, createdTime=Thu Jul 30 12:44:26 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096549, encodeId=de89209654996, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：刚收了一篇，一篇中规中矩的稿子，非主力课题的数据，投Cancer Letters拒稿后转投Molecular Oncology，修回要求补实验，补了大概2组图的数据量，二修后又提了点小问题就接受了。这个杂志对实验图片的审查是我见过最严格的，最后一轮修回，要求提交原始数据，最后我们提交了1G的原始数据，包括所有的重复。编辑校对及其细致，校对了两轮，花了一周时间。想混的还有实验重复次数不够的，还是建议不要投这个杂志了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d78400513, createdName=ms5000001747723382, createdTime=Thu Oct 27 21:39:31 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969727, encodeId=e73c969e273b, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3600.0<br>偏重的研究方向：肿瘤血管发育<br>经验分享：刚接收1篇，前期投Cancer Research不中投过来的<br>1.21投稿，3.2Major，3个reviewer，1一个小修接收，一个正常评审，一个问题较多<br>补实验2月，5.15修回，5.28接收<br>WB会要求原始曝光图及实验相关信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac4999328, createdName=fangchao1989, createdTime=Sun May 30 23:47:54 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582589, encodeId=12c458258929, content=这个杂志接收后需要提供原始曝光图吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23d05177737, createdName=向快乐出发, createdTime=Fri Jan 03 00:00:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205617, encodeId=40dc120561e35, content=各位大佬，请教下这个杂志接受临床结合生信类的文章吗，万分感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Thu Mar 24 16:56:46 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002991, encodeId=ccdb10029912d, content=请问需要wb未剪裁的原始曝光图片么？我的wb都剪过了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Tue Jul 27 13:30:51 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082042, encodeId=761a1082042a6, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：杂志比较难得投，所有的都需要原图，wb可能要全膜，谨慎选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95db5541159, createdName=阳关月, createdTime=Mon Dec 20 11:17:44 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212420, encodeId=c805121242048, content=这杂志灌水的就别考虑了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220419/0ecfdd1b0b5d452097a52e6dc6c6e9fe/95751d975cfd4fa18ac95d4cb42e701e.png, createdBy=9d361953288, createdName=222222ddwdd, createdTime=Tue Apr 19 09:13:51 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196267, encodeId=e173119626ede, content=这个杂志有些文章质量真的可以，5-10分这一档算很不错的杂志了，很少国人灌水的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1dc5574811, createdName=ms3000001264860737, createdTime=Tue Feb 22 23:12:02 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585839, encodeId=f9e1585839db, content=这个杂志是欧洲生化协会的期刊，要求高，文章水平也高，不接受review，只进行review的邀稿，所以杂志if很结实，不是用大量review强行拉上去的。如果文章水平可以，可以投一投，一般的就不要浪费时间了。而且对质量要求高，造假的甭投了，被检查出来那就有意思了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/2d0413f4fd3b4a5f1acc9ccc7d585f61.jpg, createdBy=b9cb2546102, createdName=这是一个昵称, createdTime=Wed Mar 04 00:00:00 CST 2020, time=2020-03-04, status=1, ipAttribution=)]
    2022-02-22 ms3000001264860737

    这个杂志有些文章质量真的可以，5-10分这一档算很不错的杂志了，很少国人灌水的文章

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=805187, encodeId=5e8080518e5f, content=intial check之后 Awit EIC assignment，然后就是Under Review，这是送审稿人了么？还是编辑在自己审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/f8c6cedf590b428e995d7418b12fecdf/3ca40bdbedf6430d90d6ada162ebe274.jpg, createdBy=46eb5398335, createdName=投投投中中中, createdTime=Thu Jul 30 12:44:26 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096549, encodeId=de89209654996, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：刚收了一篇，一篇中规中矩的稿子，非主力课题的数据，投Cancer Letters拒稿后转投Molecular Oncology，修回要求补实验，补了大概2组图的数据量，二修后又提了点小问题就接受了。这个杂志对实验图片的审查是我见过最严格的，最后一轮修回，要求提交原始数据，最后我们提交了1G的原始数据，包括所有的重复。编辑校对及其细致，校对了两轮，花了一周时间。想混的还有实验重复次数不够的，还是建议不要投这个杂志了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d78400513, createdName=ms5000001747723382, createdTime=Thu Oct 27 21:39:31 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969727, encodeId=e73c969e273b, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:3600.0<br>偏重的研究方向：肿瘤血管发育<br>经验分享：刚接收1篇，前期投Cancer Research不中投过来的<br>1.21投稿，3.2Major，3个reviewer，1一个小修接收，一个正常评审，一个问题较多<br>补实验2月，5.15修回，5.28接收<br>WB会要求原始曝光图及实验相关信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac4999328, createdName=fangchao1989, createdTime=Sun May 30 23:47:54 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582589, encodeId=12c458258929, content=这个杂志接收后需要提供原始曝光图吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23d05177737, createdName=向快乐出发, createdTime=Fri Jan 03 00:00:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205617, encodeId=40dc120561e35, content=各位大佬，请教下这个杂志接受临床结合生信类的文章吗，万分感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Thu Mar 24 16:56:46 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002991, encodeId=ccdb10029912d, content=请问需要wb未剪裁的原始曝光图片么？我的wb都剪过了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Tue Jul 27 13:30:51 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082042, encodeId=761a1082042a6, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：杂志比较难得投，所有的都需要原图，wb可能要全膜，谨慎选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95db5541159, createdName=阳关月, createdTime=Mon Dec 20 11:17:44 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212420, encodeId=c805121242048, content=这杂志灌水的就别考虑了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220419/0ecfdd1b0b5d452097a52e6dc6c6e9fe/95751d975cfd4fa18ac95d4cb42e701e.png, createdBy=9d361953288, createdName=222222ddwdd, createdTime=Tue Apr 19 09:13:51 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196267, encodeId=e173119626ede, content=这个杂志有些文章质量真的可以，5-10分这一档算很不错的杂志了，很少国人灌水的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1dc5574811, createdName=ms3000001264860737, createdTime=Tue Feb 22 23:12:02 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585839, encodeId=f9e1585839db, content=这个杂志是欧洲生化协会的期刊，要求高，文章水平也高，不接受review，只进行review的邀稿，所以杂志if很结实，不是用大量review强行拉上去的。如果文章水平可以，可以投一投，一般的就不要浪费时间了。而且对质量要求高，造假的甭投了，被检查出来那就有意思了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/2d0413f4fd3b4a5f1acc9ccc7d585f61.jpg, createdBy=b9cb2546102, createdName=这是一个昵称, createdTime=Wed Mar 04 00:00:00 CST 2020, time=2020-03-04, status=1, ipAttribution=)]
    2020-03-04 这是一个昵称

    这个杂志是欧洲生化协会的期刊，要求高，文章水平也高，不接受review，只进行review的邀稿，所以杂志if很结实，不是用大量review强行拉上去的。如果文章水平可以，可以投一投，一般的就不要浪费时间了。而且对质量要求高，造假的甭投了，被检查出来那就有意思了。

    1

    展开1条回复
共230条页码: 2/23页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分